Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 786

1.

Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study.

Carcel C, Neal B, Oparil S, Rogers K, Narkiewicz K, Wang JG, Schiffrin EL, Poulter N, Azizi M, Chalmers J.

J Hypertens. 2019 Aug 13. doi: 10.1097/HJH.0000000000002184. [Epub ahead of print]

PMID:
31415307
2.

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

SPRINT MIND Investigators for the SPRINT Research Group, Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB, Williamson JD, Bryan RN.

JAMA. 2019 Aug 13;322(6):524-534. doi: 10.1001/jama.2019.10551.

PMID:
31408137
3.

Sex Differences in Hypertension and Stroke Risk in the REGARDS Study.

Madsen TE, Howard G, Kleindorfer DO, Furie KL, Oparil S, Manson JE, Liu S, Howard VJ.

Hypertension. 2019 Aug 13:HYPERTENSIONAHA11912729. doi: 10.1161/HYPERTENSIONAHA.119.12729. [Epub ahead of print]

PMID:
31405299
4.

Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.

Siddiqui M, Judd EK, Dudenbostel T, Zhang B, Gupta P, Tomaszewski M, Patel P, Oparil S, Calhoun DA.

Hypertension. 2019 Sep;74(3):652-659. doi: 10.1161/HYPERTENSIONAHA.119.13258. Epub 2019 Jul 22.

PMID:
31327263
5.

Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury.

Xing D, Wells JM, Giordano SS, Feng W, Gaggar A, Yan J, Hage FG, Li L, Chen YF, Oparil S.

J Appl Physiol (1985). 2019 Aug 1;127(2):444-456. doi: 10.1152/japplphysiol.00587.2018. Epub 2019 Jul 11.

PMID:
31295064
6.

Lower Blood Pressure Thresholds Raise the Bar in Pregnancy.

Sinkey RG, Oparil S.

Circ Res. 2019 Jul 5;125(2):195-197. doi: 10.1161/CIRCRESAHA.119.315384. Epub 2019 Jul 3. No abstract available.

PMID:
31268860
7.

Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.

Upadhya B, Rocco MV, Pajewski NM, Morgan T, Blackshear J, Hundley WG, Oparil S, Soliman EZ, Cohen DL, Hamilton CA, Cho ME, Kostis WJ, Papademetriou V, Rodriguez CJ, Raj DS, Townsend R, Vasu S, Zamanian S, Kitzman DW; SPRINT Research Group * .

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11913073. doi: 10.1161/HYPERTENSIONAHA.119.13073. [Epub ahead of print]

PMID:
31256724
8.

The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction.

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2019 Aug;28(4):215-216. doi: 10.1080/08037051.2019.1625523. Epub 2019 Jun 11. No abstract available.

PMID:
31184508
9.

Blood Pressure and the Electronic Health Record: A Work in Progress.

Ahmad A, Oparil S.

J Am Heart Assoc. 2019 Jun 18;8(12):e012960. doi: 10.1161/JAHA.119.012960. Epub 2019 Jun 5.

10.

Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2019 Jun;28(3):144-145. doi: 10.1080/08037051.2019.1614278. No abstract available.

PMID:
31076016
11.

Take a Blood Pressure Pill or Benefit from Renal Denervation?

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Eur Heart J. 2018 Sep 1;39(33):3010-3012. doi: 10.1093/eurheartj/ehy440. No abstract available.

PMID:
30990870
12.

Epicardial Adipose Tissue and Cardiovascular Disease.

Le Jemtel TH, Samson R, Ayinapudi K, Singh T, Oparil S.

Curr Hypertens Rep. 2019 Apr 5;21(5):36. doi: 10.1007/s11906-019-0939-6. Review.

PMID:
30953236
13.

Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.

Johnson K, Oparil S, Davis BR, Tereshchenko LG.

J Am Heart Assoc. 2019 Apr 16;8(8):e011961. doi: 10.1161/JAHA.119.011961.

14.

Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.

Jotwani VK, Lee AK, Estrella MM, Katz R, Garimella PS, Malhotra R, Rifkin DE, Ambrosius W, Freedman BI, Cheung AK, Raphael KL, Drawz P, Neyra JA, Oparil S, Punzi H, Shlipak MG, Ix JH; for the SPRINT Research Group.

Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2.

PMID:
30939472
15.

Treatment of Resistant and Refractory Hypertension.

Acelajado MC, Hughes ZH, Oparil S, Calhoun DA.

Circ Res. 2019 Mar 29;124(7):1061-1070. doi: 10.1161/CIRCRESAHA.118.312156.

PMID:
30920924
16.

Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT.

Bowling CB, Davis BR, Luciano A, Simpson LM, Sloane R, Pieper CF, Einhorn PT, Oparil S, Muntner P.

J Clin Hypertens (Greenwich). 2019 Apr;21(4):451-459. doi: 10.1111/jch.13515. Epub 2019 Mar 13.

17.

Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2019 Apr;28(2):75-76. doi: 10.1080/08037051.2019.1584975. Epub 2019 Feb 26. No abstract available.

PMID:
30806086
18.

New data on antihypertensive drugs and risk of cancer: should we worry?

Burnier M, Narkiewicz K, Kjeldsen SE, Oparil S.

Blood Press. 2019 Feb;28(1):1-3. doi: 10.1080/08037051.2019.1568182. No abstract available.

PMID:
30714837
19.

Plasma xanthine oxidase activity is related to increased sodium and left ventricular hypertrophy in resistant hypertension.

Butts B, Calhoun DA, Denney TS Jr, Lloyd SG, Gupta H, Gaddam KK, Aban I, Oparil S, Sanders PW, Patel R, Collawn JF, Dell'Italia LJ.

Free Radic Biol Med. 2019 Apr;134:343-349. doi: 10.1016/j.freeradbiomed.2019.01.029. Epub 2019 Jan 26.

PMID:
30695690
20.

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB.

JAMA. 2019 Feb 12;321(6):553-561. doi: 10.1001/jama.2018.21442.

21.

Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.

Siddiqui M, Judd EK, Jaeger BC, Bhatt H, Dudenbostel T, Zhang B, Edwards LJ, Oparil S, Calhoun DA.

Hypertension. 2019 Jan;73(1):132-141. doi: 10.1161/HYPERTENSIONAHA.118.11818.

PMID:
30571547
22.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
23.

2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension.

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2018 Dec;27(6):313. doi: 10.1080/08037051.2018.1530564. No abstract available.

PMID:
30380927
24.

Number of Measurements Needed to Obtain a Reliable Estimate of Home Blood Pressure: Results From the Improving the Detection of Hypertension Study.

Bello NA, Schwartz JE, Kronish IM, Oparil S, Anstey DE, Wei Y, Cheung YKK, Muntner P, Shimbo D.

J Am Heart Assoc. 2018 Oct 16;7(20):e008658. doi: 10.1161/JAHA.118.008658.

25.

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.

Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, Cutler J, Fine L, Boucher R, Wei G, Zhang C, Kramer H, Bress AP, Kimmel PL, Oparil S, Lewis CE, Rahman M, Cushman WC.

J Am Heart Assoc. 2018 Sep 18;7(18):e009326. doi: 10.1161/JAHA.118.009326.

26.

Sprinting Toward the Optimal Blood Pressure Target for Hypertensive Patients.

Oparil S, Cushman WC, Johnson KC, Kitzman DW, Whelton PK, Wright JT Jr.

Circ Res. 2018 Aug 17;123(5):531-534. doi: 10.1161/CIRCRESAHA.118.313057. No abstract available.

PMID:
30355141
27.

Effect of sleeve gastrectomy on hypertension.

Samson R, Milligan G, Lewine E, Sindi F, Garagliano J, Fernandez C, Moore R, DuCoin C, Oparil S, LE Jemtel TH.

J Am Soc Hypertens. 2018 Nov;12(11):e19-e25. doi: 10.1016/j.jash.2018.09.007. Epub 2018 Sep 19.

PMID:
30322789
28.

Obesity and Pulmonary Hypertension.

Ayinapudi K, Singh T, Motwani A, Le Jemtel TH, Oparil S.

Curr Hypertens Rep. 2018 Oct 5;20(12):99. doi: 10.1007/s11906-018-0899-2. Review.

PMID:
30291516
29.

Association of Clinical and Social Factors With Excess Hypertension Risk in Black Compared With White US Adults.

Howard G, Cushman M, Moy CS, Oparil S, Muntner P, Lackland DT, Manly JJ, Flaherty ML, Judd SE, Wadley VG, Long DL, Howard VJ.

JAMA. 2018 Oct 2;320(13):1338-1348. doi: 10.1001/jama.2018.13467.

30.

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.

Supiano MA, Lovato L, Ambrosius WT, Bates J, Beddhu S, Drawz P, Dwyer JP, Hamburg NM, Kitzman D, Lash J, Lustigova E, Miracle CM, Oparil S, Raj DS, Weiner DE, Taylor A, Vita JA, Yunis R, Chertow GM, Chonchol M.

PLoS One. 2018 Sep 26;13(9):e0203305. doi: 10.1371/journal.pone.0203305. eCollection 2018.

31.
32.

Revisiting ASCOT 16 years later.

Oparil S, Fu RH.

Lancet. 2018 Sep 29;392(10153):1092-1094. doi: 10.1016/S0140-6736(18)31943-3. Epub 2018 Aug 26. No abstract available.

PMID:
30158071
33.

Novel Medical Treatments for Hypertension and Related Comorbidities.

Davis J, Oparil S.

Curr Hypertens Rep. 2018 Aug 25;20(10):90. doi: 10.1007/s11906-018-0890-y. Review.

PMID:
30145617
34.

Final Farewell to Alberto Zanchetti MD.

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Eur Heart J. 2018 Jul 21;39(28):2616-2617. doi: 10.1093/eurheartj/ehy327. No abstract available.

PMID:
30052934
35.

Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk.

Le Jemtel TH, Samson R, Milligan G, Jaiswal A, Oparil S.

Curr Hypertens Rep. 2018 Jul 10;20(9):77. doi: 10.1007/s11906-018-0880-0. Review.

PMID:
29992362
36.

Renal denervation achieved by endovascular delivery of ultrasound in RADIANCE-HTN SOLO or by radiofrequency energy in SPYRAL HTN-OFF and SPYRAL-ON lowers blood pressure.

Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S.

Blood Press. 2018 Aug;27(4):185-187. doi: 10.1080/08037051.2018.1486178. Epub 2018 Jun 25. No abstract available.

PMID:
29936868
37.

Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes.

Ives CW, AlJaroudi WA, Kumar V, Farag A, Rizk DV, Oparil S, Iskandrian AE, Hage FG.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1998-2008. doi: 10.1007/s00259-018-4068-2. Epub 2018 Jun 7.

PMID:
29882159
38.

Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes.

Velasco A, Siddiqui M, Kreps E, Kolakalapudi P, Dudenbostel T, Arora G, Judd EK, Prabhu SD, Lloyd SG, Oparil S, Calhoun DA.

Hypertension. 2018 Aug;72(2):343-349. doi: 10.1161/HYPERTENSIONAHA.118.10965. Epub 2018 Jun 4.

39.

Case of Refractory Hypertension Controlled After Aortic and Mitral Valve Replacement and Coronary Artery Bypass Grafting.

Siddiqui M, Phillips RA, Bursztyn M, Sica D, Velasco A, Judd EK, Dudenbostel T, Lloyd SG, Oparil S, Calhoun DA.

Hypertension. 2018 Jul;72(1):3-9. doi: 10.1161/HYPERTENSIONAHA.118.11155. Epub 2018 May 7. No abstract available.

40.

Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).

Shapiro BP, Ambrosius WT, Blackshear JL, Cushman WC, Whelton PK, Oparil S, Beddhu S, Dwyer JP, Gren LH, Kostis WJ, Lioudis M, Pisoni R, Rosendorff C, Haley WE; SPRINT Research Group*.

Hypertension. 2018 Jun;71(6):1064-1074. doi: 10.1161/HYPERTENSIONAHA.117.10646. Epub 2018 Apr 30.

41.

Reply.

Ahmad A, Oparil S.

J Hypertens. 2018 Jun;36(6):1423-1424. doi: 10.1097/HJH.0000000000001725. No abstract available.

PMID:
29697482
42.

O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.

Yao D, Xu L, Xu O, Li R, Chen M, Shen H, Zhu H, Zhang F, Yao D, Chen YF, Oparil S, Zhang Z, Gong K.

Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1309-1320. doi: 10.1161/ATVBAHA.117.310468. Epub 2018 Apr 5.

PMID:
29622561
43.

Hypertension.

Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, Whelton PK.

Nat Rev Dis Primers. 2018 Mar 22;4:18014. doi: 10.1038/nrdp.2018.14. Review.

44.

Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial).

Johnson KC, Whelton PK, Cushman WC, Cutler JA, Evans GW, Snyder JK, Ambrosius WT, Beddhu S, Cheung AK, Fine LJ, Lewis CE, Rahman M, Reboussin DM, Rocco MV, Oparil S, Wright JT Jr; SPRINT Research Group.

Hypertension. 2018 May;71(5):848-857. doi: 10.1161/HYPERTENSIONAHA.117.10479. Epub 2018 Mar 12.

45.

Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.

Bakris GL, Zhao L, Kupfer S, Juhasz A, Hisada M, Lloyd E, Oparil S.

J Clin Hypertens (Greenwich). 2018 Apr;20(4):694-702. doi: 10.1111/jch.13230. Epub 2018 Mar 4.

46.

Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.

Foy CG, Lovato LC, Vitolins MZ, Bates JT, Campbell R, Cushman WC, Glasser SP, Gillespie A, Kostis WJ, Krousel-Wood M, Muhlestein JB, Oparil S, Osei K, Pisoni R, Segal MS, Wiggers A, Johnson KC; SPRINT Study Research Group.

J Hypertens. 2018 Apr;36(4):904-915. doi: 10.1097/HJH.0000000000001619.

PMID:
29493562
47.

New 2017 American Heart Association and American College of Cardiology guideline for hypertension in the adults: major paradigm shifts, but will they help to fight against the hypertension disease burden?

Burnier M, Oparil S, Narkiewicz K, Kjeldsen SE.

Blood Press. 2018 Apr;27(2):62-65. doi: 10.1080/08037051.2018.1430504. Epub 2018 Feb 15. No abstract available.

PMID:
29447001
48.

Impact of the SPRINT Trial on Hypertension Management.

Ghazi L, Oparil S.

Annu Rev Med. 2018 Jan 29;69:81-95. doi: 10.1146/annurev-med-050416-024516.

PMID:
29414255
49.

Accuracy of Blood Pressure Measurement Devices in Pregnancy: A Systematic Review of Validation Studies.

Bello NA, Woolley JJ, Cleary KL, Falzon L, Alpert BS, Oparil S, Cutter G, Wapner R, Muntner P, Tita AT, Shimbo D.

Hypertension. 2018 Feb;71(2):326-335. doi: 10.1161/HYPERTENSIONAHA.117.10295. Epub 2017 Dec 11. Review.

50.

What is the most appropriate target SBP in persons with hypertension and diabetes mellitus?

Ahmad A, Oparil S.

J Hypertens. 2018 Jan;36(1):37-40. doi: 10.1097/HJH.0000000000001603. No abstract available.

PMID:
29210858

Supplemental Content

Loading ...
Support Center